Section Arrow
Quote
CRNX.NASDAQ
- Crinetics Pharmaceuticals
Quotes are at least 15-min delayed:2025/09/03 21:26 EDT
Regular Hours
Last
 34.65
+1.35 (+4.05%)
Day High 
35.21 
Prev. Close
33.3 
1-M High
33.44 
Volume 
1.77M 
Bid
34.4
Ask
36.55
Day Low
33.055 
Open
33.1 
1-M Low
25.83 
Market Cap 
3.14B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 30.52 
20-SMA 29.69 
50-SMA 30.09 
52-W High 62.53 
52-W Low 24.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.10/-6.13
Enterprise Value
3.18B
Balance Sheet
Book Value Per Share
12.44
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.04M
Operating Revenue Per Share
0.05
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PMNProMIS Neurosciences0.4574-0.0792-14.76%6.98PE
ADAPAdaptimmune Therapeutics plc0.0526-0.0052-9.00%-- 
CARMCarisma Therapeutics0.3699-0.0701-15.93%-- 
ETHZETHZilla Corporation2.52-0.15-5.62%-- 
STTKShattuck Labs1.28+0.27+26.73%-- 
Quotes are at least 15-min delayed：2025/09/03 21:26 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.